Search
for
Sort by
Research 91–120 of 1000+
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- The Clinical Presentation of Systemic Lupus Erythematosus
- Tinea capitis in adult women masquerading as bacterial pyoderma
- Scalp Itch: A Systematic Review
- Review of Cardiovascular Findings in Humans Treated with Minoxidil
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Interventions for morphea
- Cicatricial alopecia
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Skin disorders associated with the COVID‐19 pandemic: A review
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Symptom management in inflammatory bowel disease
- Psychotropic Medications and the Skin
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Rheumatologic Manifestations of Pregnancy
- Cytokines
- Management of Toxicities of Targeted Therapies
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- Atlas of Geriatric Dermatology
- Mnemonics in dermatology
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons